Search Results

You are looking at 1 - 1 of 1 items for

  • Author or Editor: Michael C. Hiles x
  • Refine by Access: Content accessible to me x
Clear All Modify Search


In dogs, gastric dilatation-volvulus (gdv) is characterized by cardiogenic shock, with resulting hypoperfusion. Treatment goals include reperfusion of transiently ischemic tissues, which indicates that reperfusion injury may be a factor in the physiopathogenesis of gdv. Recently, we obtained data that indicate that reperfusion injury may be involved in experimentally induced gdv. Using this gdv model, we evaluated mortality in 24 dogs of 4 equal groups, treated with deferoxamine (an iron chelator), dimethylsulfoxide (a free radical scavenger), a combination of the 2 drugs, or isotonic saline solution. All 6 dogs that were given deferoxamine survived; however, 3 dogs of the dimethylsulfoxide-treated group, 2 dogs of the combination-treated group, and 4 dogs of the saline-treated group died. Results of the study indicate that mortality associated with experimentally induced gdv is reduced by appropriate and timely pharmacologic intervention to prevent or attenuate reperfusion injury, and that deferoxamine may be more effective than dimethylsulfoxide.

Free access
in American Journal of Veterinary Research